Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 123

1.

Budget impact analysis of 8 hormonal contraceptive options.

Crespi S, Kerrigan M, Sood V.

Am J Manag Care. 2013 Jul 1;19(7):e249-55.

2.
3.

Hormonal contraceptives for contraception in overweight or obese women.

Lopez LM, Bernholc A, Chen M, Grey TW, Otterness C, Westhoff C, Edelman A, Helmerhorst FM.

Cochrane Database Syst Rev. 2016 Aug 18;(8):CD008452. doi: 10.1002/14651858.CD008452.pub4. Review.

PMID:
27537097
4.

Achieving cost-neutrality with long-acting reversible contraceptive methods.

Trussell J, Hassan F, Lowin J, Law A, Filonenko A.

Contraception. 2015 Jan;91(1):49-56. doi: 10.1016/j.contraception.2014.08.011. Epub 2014 Sep 6.

5.

Cost effectiveness of contraceptives in the United States.

Trussell J, Lalla AM, Doan QV, Reyes E, Pinto L, Gricar J.

Contraception. 2009 Jan;79(1):5-14. doi: 10.1016/j.contraception.2008.08.003. Epub 2008 Sep 25. Erratum in: Contraception. 2009 Aug;80(2):229-30.

6.
7.

Use of the etonogestrel implant and levonorgestrel intrauterine device beyond the U.S. Food and Drug Administration-approved duration.

McNicholas C, Maddipati R, Zhao Q, Swor E, Peipert JF.

Obstet Gynecol. 2015 Mar;125(3):599-604. doi: 10.1097/AOG.0000000000000690.

8.

A multicenter randomized clinical trial of one-rod etonogestrel and two-rod levonorgestrel contraceptive implants with nonrandomized copper-IUD controls: methodology and insertion data.

Meirik O, Brache V, Orawan K, Habib NA, Schmidt J, Ortayli N, Culwell K, Jackson E, Ali M; WHO Study Group on Contraceptive Implants for Women.

Contraception. 2013 Jan;87(1):113-20. doi: 10.1016/j.contraception.2012.08.044. Epub 2012 Oct 10.

PMID:
23063337
9.

Continuation and satisfaction of reversible contraception.

Peipert JF, Zhao Q, Allsworth JE, Petrosky E, Madden T, Eisenberg D, Secura G.

Obstet Gynecol. 2011 May;117(5):1105-13. doi: 10.1097/AOG.0b013e31821188ad.

10.

Hormonally impregnated intrauterine systems (IUSs) versus other forms of reversible contraceptives as effective methods of preventing pregnancy.

French R, Van Vliet H, Cowan F, Mansour D, Morris S, Hughes D, Robinson A, Proctor T, Summerbell C, Logan S, Helmerhorst F, Guillebaud J.

Cochrane Database Syst Rev. 2004;(3):CD001776. Review.

PMID:
15266453
11.

The economic value of contraception: a comparison of 15 methods.

Trussell J, Leveque JA, Koenig JD, London R, Borden S, Henneberry J, LaGuardia KD, Stewart F, Wilson TG, Wysocki S, et al.

Am J Public Health. 1995 Apr;85(4):494-503.

13.

Rates and outcomes of planned pregnancy after use of Norplant capsules, Norplant II rods, or levonorgestrel-releasing or copper TCu 380Ag intrauterine contraceptive devices.

Sivin I, Stern J, Diaz S, Pav├ęz M, Alvarez F, Brache V, Mishell DR Jr, Lacarra M, McCarthy T, Holma P, et al.

Am J Obstet Gynecol. 1992 Apr;166(4):1208-13.

PMID:
1566771
14.

Extended use up to 5 years of the etonogestrel-releasing subdermal contraceptive implant: comparison to levonorgestrel-releasing subdermal implant.

Ali M, Akin A, Bahamondes L, Brache V, Habib N, Landoulsi S, Hubacher D; WHO study group on subdermal contraceptive implants for women .

Hum Reprod. 2016 Nov;31(11):2491-2498. Epub 2016 Sep 26.

15.
16.
17.

Menstrual impact of contraception.

Stubblefield PG.

Am J Obstet Gynecol. 1994 May;170(5 Pt 2):1513-22. Review.

PMID:
8178900
18.

Blood pressure changes and hormonal contraceptives.

Shen Q, Lin D, Jiang X, Li H, Zhang Z.

Contraception. 1994 Aug;50(2):131-41.

PMID:
7956212
19.

Acceptability of IUDs is increasing.

Finger WR, Barr D.

Netw Res Triangle Park N C. 1992 Oct;13(2):27-30.

PMID:
12286082
20.

Intrauterine devices: an effective alternative to oral hormonal contraception.

[No authors listed]

Prescrire Int. 2009 Jun;18(101):125-30.

PMID:
19637436

Supplemental Content

Support Center